269 related articles for article (PubMed ID: 16621031)
21. Murine B7 antigen provides a sufficient costimulatory signal for antigen-specific and MHC-restricted T cell activation.
Galvin F; Freeman GJ; Razi-Wolf Z; Hall W; Benacerraf B; Nadler L; Reiser H
J Immunol; 1992 Dec; 149(12):3802-8. PubMed ID: 1281187
[TBL] [Abstract][Full Text] [Related]
22. Construction and characterization of bispecific costimulatory molecules containing a minimized CD86 (B7-2) domain and single-chain antibody fragments for tumor targeting.
Rohrbach F; Gerstmayer B; Biburger M; Wels W
Clin Cancer Res; 2000 Nov; 6(11):4314-22. PubMed ID: 11106249
[TBL] [Abstract][Full Text] [Related]
23. Dual expression of human leukocyte antigen molecules and the B7-1 costimulatory molecule (CD80) on human melanoma cells after particle-mediated gene transfer.
Albertini MR; Emler CA; Schell K; Tans KJ; King DM; Sheehy MJ
Cancer Gene Ther; 1996; 3(3):192-201. PubMed ID: 8725884
[TBL] [Abstract][Full Text] [Related]
24. Intraperitoneal Echinococcus multilocularis infection in C57BL/6 mice affects CD40 and B7 costimulator expression on peritoneal macrophages and impairs peritoneal T cell activation.
Mejri N; Gottstein B
Parasite Immunol; 2006 Aug; 28(8):373-85. PubMed ID: 16879309
[TBL] [Abstract][Full Text] [Related]
25. The immunological synapse and CD28-CD80 interactions.
Bromley SK; Iaboni A; Davis SJ; Whitty A; Green JM; Shaw AS; Weiss A; Dustin ML
Nat Immunol; 2001 Dec; 2(12):1159-66. PubMed ID: 11713465
[TBL] [Abstract][Full Text] [Related]
26. Complete rejection of a T-cell lymphoma due to synergism of T-cell receptor costimulatory molecules, CD80, CD40L, and CD40.
Ruybal P; Gravisaco MJ; Barcala V; Escalada A; Di Sciullo P; Waldner C; Mongini C
Vaccine; 2008 Jan; 26(5):697-705. PubMed ID: 18155328
[TBL] [Abstract][Full Text] [Related]
27. The effect of co-expression costimulatory molecule CD80 on uptake of antigen peptide-MHC class I-GFP complex by specific T cells.
Liu X; Zhang L; Zhang X; Yu H; Zhao X; Lu J; Qian G; Ge S
Int J Oncol; 2007 Jun; 30(6):1389-96. PubMed ID: 17487359
[TBL] [Abstract][Full Text] [Related]
28. B7.1 costimulation increases T-cell proliferation and cytotoxicity via selective expansion of specific variable alpha and beta genes of the T-cell receptor.
Chan AK; Goedegebuure PS; von Bernstorff W; Carritte AL; Chung M; Stewart RA; Montgomery L; Spanjaard RA; McKenzie AB; Eberlein TJ
Surgery; 2000 Mar; 127(3):342-50. PubMed ID: 10715992
[TBL] [Abstract][Full Text] [Related]
29. Combination B7-Fc fusion protein treatment and Treg cell depletion therapy.
Liu A; Hu P; Khawli LA; Epstein AL
Clin Cancer Res; 2005 Dec; 11(23):8492-502. PubMed ID: 16322313
[TBL] [Abstract][Full Text] [Related]
30. Induction of costimulatory molecule B7 in M12 B lymphomas by cAMP or MHC-restricted T cell interaction.
Watts TH; Alaverdi N; Wade WF; Linsley PS
J Immunol; 1993 Mar; 150(6):2192-202. PubMed ID: 7680686
[TBL] [Abstract][Full Text] [Related]
31. Expression of fusion IL2-B7.1(IgV+C) and effects on T lymphocytes.
Kong L; Li Y; Yang Y; Li K
Biochem Cell Biol; 2007 Dec; 85(6):685-95. PubMed ID: 18059527
[TBL] [Abstract][Full Text] [Related]
32. T lymphocyte T cell-B cell-activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity.
Yellin MJ; Sinning J; Covey LR; Sherman W; Lee JJ; Glickman-Nir E; Sippel KC; Rogers J; Cleary AM; Parker M
J Immunol; 1994 Jul; 153(2):666-74. PubMed ID: 7517421
[TBL] [Abstract][Full Text] [Related]
33. A mutant B7-1/Ig fusion protein that selectively binds to CTLA-4 ameliorates anti-tumor DNA vaccination and counters regulatory T cell activity.
Chakrabarti R; Zhou ZF; Chang Y; Prud'homme GJ
Vaccine; 2005 Aug; 23(37):4553-64. PubMed ID: 15919138
[TBL] [Abstract][Full Text] [Related]
34. Costimulation of T cell proliferation by a chimeric B7-2 antibody fusion protein specifically targeted to cells expressing the erbB2 proto-oncogene.
Gerstmayer B; Altenschmidt U; Hoffmann M; Wels W
J Immunol; 1997 May; 158(10):4584-90. PubMed ID: 9144470
[TBL] [Abstract][Full Text] [Related]
35. Time courses of B7 family molecules expressed on activated T-cells and their biological significance.
Sun ZW; Qiu YH; Shi YJ; Tao R; Chen J; Ge Y; Hu YM; Ma HB; Shi Q; Zhang XG
Cell Immunol; 2005; 236(1-2):146-53. PubMed ID: 16165113
[TBL] [Abstract][Full Text] [Related]
36. Gene transfer of AIMP1 and B7.1 into epitope-loaded, fibroblasts induces tumor-specific CTL immunity, and prolongs the survival period of tumor-bearing mice.
Kim TS; Lee BC; Kim E; Cho D; Cohen EP
Vaccine; 2008 Nov; 26(47):5928-34. PubMed ID: 18793691
[TBL] [Abstract][Full Text] [Related]
37. Allogeneic lymphocyte responses to B7-1 expressing human cancer cell lines.
Dessureault S; Gallinger S
J Surg Res; 1996 Jul; 64(1):42-8. PubMed ID: 8806472
[TBL] [Abstract][Full Text] [Related]
38. Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 costimulatory molecules.
Hodge JW; Abrams S; Schlom J; Kantor JA
Cancer Res; 1994 Nov; 54(21):5552-5. PubMed ID: 7522961
[TBL] [Abstract][Full Text] [Related]
39. Intramuscular gene transfer of soluble B7.1/IgG(1) fusion cDNA induces potent antitumor immunity as an adjuvant for DNA vaccination.
Zhou ZF; Peretz Y; Chang Y; Miao DS; Li X; Prud'homme GJ
Cancer Gene Ther; 2003 Jun; 10(6):491-9. PubMed ID: 12768195
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic antitumor response to cervical cancer in mice immunized with U14 vaccines transfected with costimulatory B7 gene.
Tao G; Hu J; Zou H; Lin Q; Liu F; Wu Y; Sun Q
Chin Med J (Engl); 2001 Jun; 114(6):623-7. PubMed ID: 11780440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
